Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients

BACKGROUND: Currently, no clearly superior management strategy exists for recurrent, platinum-resistant ovarian cancer. We tested the efficacy and safety of gemcitabine combined with oxaliplatin (GEMOX) in a multicentre phase II clinical trial. METHODS: Forty one patients with recurrent, platinum-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Vici, Patrizia, Sergi, Domenico, Pizzuti, Laura, Mariani, Luciano, Arena, Maria Grazia, Barba, Maddalena, Maugeri-Saccà, Marcello, Vincenzoni, Cristina, Vizza, Enrico, Corrado, Giacomo, Paoletti, Giancarlo, Tomao, Federica, Tomao, Silverio, Giannarelli, Diana, Di Lauro, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750635/
https://www.ncbi.nlm.nih.gov/pubmed/23927758
http://dx.doi.org/10.1186/1756-9966-32-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750635/
https://www.ncbi.nlm.nih.gov/pubmed/23927758
http://dx.doi.org/10.1186/1756-9966-32-49

Ejemplares similares